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SUMMARY
Objective: The analgesic activity of crude aqueous 
extract of the root bark of Zanthoxylum xanthozyloides
was studied in mice and rats with the view to verifying 
the claim in folklore medicine that the extract has anal-
gesic activity.
Method: The extract was obtained by Soxhlet extrac-
tion and rotatory evaporation, followed by freeze-
drying.  Groups of rats and mice were, respectively, 
assigned randomly to treatment groups.  The animals 
received three different treatments orally:  0.9% saline 
(control), the extract (400mg/kg and 800mg/kg for 
mice; 1000mg/kg and 2000mg/kg for rats) and indo-
methacin (5mg/kg and 10mg/kg for mice; 10mg/kg and 
20mg/kg for rats).  Each group of animals was rotated 
through the entire treatment groups such that each ani-
mal served as control as well as received all the treat-
ments.  The hot-plate and paw-pressure methods were 
used to study pain perception in the treated animals.  
Analysis of variance was used as the statistical test. 
Results: In both methods, the extract and indomethacin 
caused dose-dependent elevation in pain threshold. At 
the peak of activity, 400mg/kg and 800mg/kg extract 
caused 74% and 95% increase in the reaction time re-
spectively whilst 5mg/kg and 10mg/kg indomethacin 
gave 97% and 116% increment respectively. Similarly, 
1000mg/kg and 2000mg/kg extract caused 65% and 
84% increase in pain threshold whilst 10mg/kg and 
20mg/kg indomethacin caused 95% and 113% incre-
ment respectively.   
Conclusion: It was concluded that the extract induced 
analgesia, probably, by inhibiting prostaglandin pro-
duction, just as did indomethacin. 
Key Words: root bark extract, Zanthoxylum xanthoxy-
loides, pain threshold, analgesia.
INTRODUCTION
Crude aqueous extract of the root bark of Z. xanthoxy-
loides is used in Ghana and Nigeria for its anti-
rheumatic activity, anti-sickling, anti-microbial, anti-
inflammatory and analgesic properties, for example, in 
the treatment of painful conditions in childbirth and 
toothache. The extract is also used as an antiseptic.1
Isolated and purified alkaloids of the root bark, namely, 
3, 4-dihydro-2-diurethyl-2H-1- benzopyran-6-butyric 
acid (DBA), a benzopyran butyric acid derivative of 
zanthoxylol and piperonyl-4-acrylic isobutylamide 
(fagaramide)2, have been identified to have anti-
prostaglandin synthetase activity as well as anti-
inflammatory activity, using plethysmometry method. 
The former activity, which is responsible for inhibition 
of prostaglandin synthesis, contributes to the anti-
inflammatory activity of fagaramide.
The plethysmometry method2 established the anti-
inflammatory activity but not the analgesic activity of 
fagaramide.  Since the extract is used mainly as analge-
sic agent, investigation into the effect of the extract on 
pain threshold became particularly relevant. This 
would provide scientific basis for its use in folklore 
medicine and, also, for the search of cheap and safe 
herbal medication for relieving pain. The conventional 
NSAIDs have been associated with serious adverse 
effects whilst the relatively safe COX-II selective in-
hibitors are expensive and not available to most of the 
Ghanaian populace.
For the purpose of studying the analgesic activity of the 
extract, experimental models for measuring pain 
threshold, namely, hot-plate3 and rat paw-pressure4
methods were chosen. All the doses of the extract used 
were within the dose range (on the dose axis) corre-
sponding to the linear portion of the log dose-response 
curve.
MATERIALS AND METHODS 
Collection and extraction of the root bark
The roots of Z. xanthoxyloides (identified and con-
firmed in the Department of Botany, University of 
Ghana, Legon) were collected from a forest at Akatsi, 
Volta Region, in the month of August and solar-dried 
for 1 day. The root barks were removed, washed, and 
dried in hot oven (55OC) for five days. The dried root 
barks were pulverized to powder. Aliquot of the pow-
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der, 300g, was extracted in water, 3L, in Soxhlet appa-
ratus.5 The extraction was allowed to continue until a 
point where no more brown colouration was imparted 
to the water. This was used as an index for completion 
of extraction. The clear brown extract was concentrated 
10-fold in a rotatory evaporator (Bibby Sterilin Rota-
tory evaporator RE - 100). The viscous brown fluid 
was freeze-dried in Edward Modulyo freeze-drier (Ed-
wards High Vacuum). The freeze-dried powder was 
stored at –18oC until when needed. Reconstituted 
freeze-dried powder in 0.9% saline is referred to as 
“the extract” in this text.  
Hot-plate method
Preliminary study of the phenomenon of adaptation of 
nociceptors to repetitive application of stimulus was 
undertaken to determine the onset and time span of the 
adaptation. This knowledge was required to administer 
the extract and measure the pain threshold at a time 
when there was no adaptation, i.e., to determine the 
appropriate dosing interval. The adaptation was studied 
by examining the relationship between responses to 
thermal pain and varying frequency of the stimulus 
application. The study showed that the onset of adapta-
tion was directly related to the frequency of stimulus 
application and that no adaptation occurred when the 
stimulus was applied at 3-day intervals. Consequently, 
the effect of the extract on pain threshold was studied 
at 3-day intervals.
Twenty five Balb/C mice (25-35g) of both sexes (13 
males and 12 females) were randomly assigned to 5 
treatment groups of 5 mice each. One group received 
0.9% saline on weight basis  (control); two groups 
were given two dose levels of indomethacin, 5mg/kg 
and 10mg/kg respectively; and the remaining two 
groups given the extract at two dose levels, 400mg/kg 
and 800mg/kg respectively.  Each mouse was placed 
on a hotplate (55oC) and the time lapse for the mouse 
to respond to the thermal pain (reaction time) was 
noted. Rubbing of palms or jumping was used as end-
point.  The reaction time was determined at 0, 1, 2, 3, 
and 5hr after each treatment.  Each group of mice was 
rotated through the entire five treatment groups (ran-
domized complete block design) at 3-day intervals, and 
reaction time determined in each rotation.  Thus each 
mouse served as a control as well as received the other 
four treatments, i.e., the mice were self-matched. The 
mice were rested for one week after every two rota-
tions.
The mean reaction time for each treated group was 
determined and compared with that obtained for each 
group before treatment.  Percentage increase in reac-
tion time, I%, was derived, using the formula6 I% 
= {(It – Io)/Io} x 100 Where It = reaction time at 
time, t, and Io = reaction time at time zero (0)
A graph of percentage increase in reaction time was 
plotted against time.  Analysis of variance (MegaStat, 
excel) was used to compare the means of the reaction 
time of the different groups.  Post hoc analysis (after-
test ANOVA) was employed to compare the means of 
paired observations. Differences at p< 0.05 were con-
sidered significant.
Paw-pressure method
Preliminary study of the time course of the analgesic 
activity of carrageenin in the rat paw was undertaken to 
determine time to peak analgesic activity which was 
used as an index of the time lapse to attain peak con-
centration of the agent at the site of action. This was 
used to determine the dosing interval between carra-
geenin and the extract or indomethacin as well as the 
duration of each study. After treatment with 0.1ml of 
1% (w/v) carrageenin in 0.9% saline, reduction in pain 
threshold was detectable after 1 hr, reached a nadir at 3 
hr, and thereafter remained constant until 7hr when a 
gradual increase in pain threshold became manifest. 
The effect of the extract on pain threshold was, there-
fore, studied by administering the extract 2 hr after 
treatment with carrageenin, and each study was limited 
to 5 hr period. The oedema of the paw usually resolved 
within 2-3 days.
Twenty five Wistar rats (150-200g) of both sexes (12 
males and 13 females) were randomly assigned to 5 
treatment groups of 5 rats each. 0.1ml of 1% (w/v) car-
rageenin in 0.9% saline was injected into the subplantar 
surface of the right hind paw of each rat to induce in-
flammation.  The pain threshold of the treated paw was 
measured in a Basile analgesy-meter 2hr after injection 
of the inflammatory agent.  Thereafter, the rats were 
treated as follows: one group received 0.9% saline on 
weight basis (control); two groups received two dose 
levels of indomethacin, 10mg/kg and 20mg/kg; the 
remaining two groups were given the extract at two 
dose levels, 1000mg/kg and 2000mg/kg respectively.  
The pain threshold was measured again at 1, 2, 3, and 
5hr after the treatment. Each group of rats was rotated 
through the entire five treatment groups, and the pain 
threshold measured in each rotation.  Thus each rat 
served as a control as well as received the other four 
treatments. The hind paws used for induction of in-
flammation were alternated during the rotations, and 
the animals were rested for one week after every two 
rotations at 3-day interval.
Data Analysis
The mean pain threshold for each treated group was 
determined and compared with that obtained for each 
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group before treatment.  Percentage increase in pain 
threshold, P%, was derived, using the formula6 P% = 
{(Pt – Po)/Po} x 100 where Pt = pain threshold at time, 
t, and Po = pain threshold at time zero (0). A graph of 
the percentage increase in pain threshold was plotted 
against time. The results are presented as mean+SEM. 
The presence of significant differences among group 
means was determined by one way ANOVA using 
(MegaStat, Excel) followed by the Newman-Keuls 
multiple comparison test with the level of significance 
at p < 0.05.
RESULTS
In the hot-plate method, both the extract and indo-
methacin caused significant increase (p<0.05) in the 
reaction time whilst normal saline caused no change. 
The percentage increase in the reaction time was dose-
dependent and differed significantly among the groups 
of mice (p<0.05) receiving different dose levels of the 
extract and indomethacin (Table 1) 
Table 1: Observations of percentage increase in reac-
tion time in groups of mice given different dose levels 
of the extract and indomethacin. 
The percentage increase in the reaction time caused by 
the extract and indomethacin was detectable and 
peaked at 1hr and 2hr respectively but thereafter de-
clined relatively to a nadir at 5hr after the administra-
tion of the extract or indomethacin (Figure 1)
Although the activity (percentage increase in reaction 
time)/time profile was identical for the extract and in-
domethacin, the rising phase of the curve was steeper 
for indomethacin than the extract but the converse was 
true during the declining phase. At 5hr after admini-
stration, indomethacin retained a significantly greater 
activity (p < 0.05) than the extract.
At all the specified time intervals, the percentage in-
crease in reaction time differed significantly (p< 0.05) 
between the extract and indomethacin at both dose lev-
els, being greater for indomethacin except 1hr after the 
administration when there was no difference 
(p=0.8756) in the effect between the extract and indo-
methacin at high dose levels, and at 2hr when the high 
dose extract (800mg/kg) and low dose indomethacin 
(5mg/kg) caused similar percentage increase in the 
reaction time (p=0.6654)
At the peak of activity, 400mg/kg and 800mg/kg ex-
tract caused 74% and 95% increase in the reaction time 
respectively whilst 5mg/kg and 10mg/kg indomethacin 
gave 97% and 116% increment respectively. Time to 
peak activity was the same (2hr) for the extract and 
indomethacin at both dose levels.
In the paw pressure method, there was significant dif-
ference in mean pain threshold among groups of rats 
(p<0.05) receiving different dose levels of the extract 
and indomethacin. The extract significantly (p<0.05) 
elevated pain threshold dose-dependently (Table 2) in 
the carrageenin pretreated rats, with the maximum ele-
vation occurring 2hr after the administration (Fig 2). 
Indomethacin, like the extract, showed significant 
dose-dependent elevation (p<0.05) in pain threshold 
(Table 2). Compared to the extract, indomethacin 
caused a significantly greater elevation in pain thresh-
old (p<0.05) at both dose levels at all the specified time 
intervals except at 1hr after treatment when there was 
no significant difference (p=0.7381) between the ex-
tract, 2000mg/kg, and indomethacin, 10mg/kg, which 
caused 44% and 48% elevation in pain threshold re-
spectively.
Table 2: Observations of percentage increase in pain 
threshold in groups of rats given different dose levels 
of the extract and indomethacin. 
Paired Observations
(Means ± SEM)
    p-value
Extract 400mg       :  Extract 800mg
(51.96 ± 9.19)               (66.81 ± 11.24)
         
0.0051
Extract 400mg       :  Indomethacin 5mg
(51.96 ± 9.19)              (77.80 ± 8.03)
         
0.0011
Extract 400mg       :  Indomethacin 10mg
(51.96 ± 9.19)              (90.04 ± 9.59)
         
0.0007
Extract 800mg       :  Indomethacin 5mg
(66.81 ± 11.24)            (77.80 ± 8.03)
         
0.1198
Extract 800mg       :  Indomethacin 10mg
(66.81 ± 11.24)            (90.04 ± 9.59)
         
0.0182
Indomethacin 5mg:  Indomethacin 10mg
(77.80 ± 8.03)             (90.04 ± 9.59)




    p-
value  
Extract 400mg         :  Extract 800mg
(51.96 ± 9.19)               (66.81 ± 11.24)
         
0.0051
Extract 400mg         :  Indomethacin 5mg
(51.96 ± 9.19)              (77.80 ± 8.03)
         
0.0011
Extract 400mg         :  Indomethacin 10mg
(51.96 ± 9.19)              (90.04 ± 9.59)
         
0.0007
Extract 800mg          :  Indomethacin 5mg
(66.81 ± 11.24)            (77.80 ± 8.03)
         
0.1198
Extract 800mg          :  Indomethacin 10mg
(66.81 ± 11.24)            (90.04 ± 9.59)
         
0.0182
Indomethacin 5mg  :  Indomethacin 10mg
(77.80 ± 8.03)             (90.04 ± 9.59)
         
0.0045
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As it was the case in the hot-plate method, the profile 
of the pain threshold/time curve was similar for the 
extract and indomethacin (Figure 2). Similarly, the 
rising phase of the curve was steeper for indomethacin 
than the extract whilst the converse was true during the 
declining phase. Indomethacin thus retained a signifi-
cantly greater activity (p<0.05) than the extract 5hr 
after their administration. Time to peak activity was the 
same (2hr) for the extract and indomethacin.
Figure 1: Percentage increase in reaction time in mice treated with extract (♦–♦, 400mg/kg; and ■–■, 800mg/kg) and indo-
methacin (▲–▲, 5mg/kg; and □–□, 10mg/kg). Each point represents the mean percentage increase in reaction time ± SEM (n = 
25 mice).
Figure 2: Percentage increase in pain threshold caused by extract (♦–♦, 1000mg/kg; and ■–■; 2000mg/kg) and indomethacin 
(▲–▲, 10mg/kg; and □–□, 20mg/kg). Each point represents the mean percentage increase in pain threshold ± SEM (n = 25 rats)
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DISCUSSION
In the two models used, the data show that the extract 
and indomethacin dose-dependently increased the pain 
threshold, and that the pain threshold/time profiles of 
indomethacin and the extract were similar (Figures 1 
and 2).
Even though the profiles of the extract and indometha-
cin curves were similar, they differed in certain details. 
The rising phase of the indomethacin curve was steeper 
than that of the extract whilst the converse was true for 
the declining phase. Based on the fact that most drugs, 
including non-steroidal anti-inflammatory drugs 
(NSAIDs), must be present at the site of action for the 
maintenance of pharmacological response, the profile 
of the curves may be related to pharmacokinetic prop-
erties of the drugs. A very highly lipid-soluble drug, 
like indomethacin7, would be expected to be absorbed 
at a fast rate across the lipid bi-layer of the gastrointes-
tinal tract (GIT) and build up quickly in plasma result-
ing in the steep rising phase of the curve. Also, indo-
methacin would distribute widely to most tissues and 
hence have large volume of distribution. It would, 
therefore, take a long time for indomethacin to be 
eliminated from the body, as reflected by the slow de-
clining phase of the curve. The extract, on the other 
hand, is water-soluble and, as such, would be absorbed 
slowly across the lipid bi-layer of the GIT, build up 
slowly in plasma and distribute poorly to the tissues. 
The extract would thus exhibit slow entry into the cir-
culation but rapid elimination from the body, giving 
rise to slow rising phase but fast declining phase re-
spectively. As a corollary, the extract would have a 
shorter duration of action than indomethacin.
The increase in pain threshold indicates that the extract 
has analgesic property similar to indomethacin, a stan-
dard NSAID. Similar results obtained in rats, by using 
the paw pressure method, showed that 2.5mg/kg indo-
methacin caused 48% increase in pain threshold; 
200mg/kg aspirin, 51%; 25mg/kg phenylbutazone, 
52%; and 9mg/kg naproxen, 42%8. The values pre-
sented in this study are congruent with those reported, 
though large doses of the extract were required to 
achieve comparable responses. The large doses of the 
extract used could be explained by the fact that the 
crude extract contains many compounds, among which 
the active principle responsible for analgesia occurs in 
minute quantity. 
It is now well established that chemical mediators are 
responsible for the pain of inflammation.  Inhibition of 
the synthesis and release of prostaglandin has been 
shown to be the major mechanism by which NSAIDs 
produce analgesia or reduce inflammation9. By this 
action, NSAIDs reduce the sensitization of afferent 
neurons by prostaglandins to the algesic actions of bra-
dykinin and other pain provoking stimuli. As isolated 
and purified alkaloids of the root bark of Z. xanthoxy-
loids also have anti-prostaglandin synthetase activity2, 
it is most likely that the extract, like indomethacin and 
other NSAIDs, might induce analgesia by inhibiting 
the production and release of prostaglandins or block-
ing their receptors.
Following injury or injection of carrageenin, it takes 
2hr for prostaglandin to be released11, a time period 
equivalent to the time lapse between the administra-
tions of carrageenin and the extract or indomethacin. 
Thus the time lapse or dosing interval used in the paw-
pressure method was adequate to permit the release of 
prostaglandin.  However, prostaglandin could not be 
implicated in the mediation of pain in the hot-plate 
method since responses of mice to thermal stimulus 
occurred within seconds, a time too short to permit the 
release of prostaglandin. This suggests that chemical 
mediators other than prostaglandin may be involved in 
the mediation of pain. Mediators of inflammation are 
released sequentially with histamine and serotonin be-
ing the first to be released within the first 30min, fol-
lowed by kinins which are released about 1 hr and 
prostaglandins, 2hr after induction of inflammation10. 
Because the analgesic property of the extract was also 
demonstrated in the hot-plate method, it could mean 
that the extract in addition to inhibiting prostaglandin 
may also interfere with the metabolism of other algesic 
agents or block the receptor sites of these agents.
CONCLUSION
Both the paw-pressure and hot-plate methods have 
been used to show that crude aqueous extract of the 
root bark of Z. xanthoxyloides has analgesic activity, 
underscoring its use in folklore medicine to relieve 
certain painful conditions. Since isolated and purified 
alkaloids of the root bark of Z. xanthoxyloides have 
anti-prostaglandin synthetase activity, it is possible that 
the analgesic activity of the extract may involve, 
mainly, inhibition of prostaglandin synthesis but inter-
ference of the metabolism of other algesic agents or 
blockade of their receptors could not be excluded.  Fur-
ther work is required to identify molecular mecha-
nism(s) underlying the analgesic activity and, also, 
selectivity of COX I and II inhibitory activity of the 
extract. 
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